Difference between revisions of "Team:UCopenhagen"
| Line 123: | Line 123: | ||
<!-- Footer --> | <!-- Footer --> | ||
| − | |||
<div id="page-top" data-spy="scroll" data-target=".navbar-fixed-top"> | <div id="page-top" data-spy="scroll" data-target=".navbar-fixed-top"> | ||
<!-- One-Page Scroll NavBar --> | <!-- One-Page Scroll NavBar --> | ||
| Line 129: | Line 128: | ||
<div class="container"> | <div class="container"> | ||
<div class="navbar-header"> | <div class="navbar-header"> | ||
| − | |||
| − | |||
| − | |||
<a class="page-scroll" href="#">Top</a> | <a class="page-scroll" href="#">Top</a> | ||
</div> | </div> | ||
<!-- Collect the nav links, forms, and other content for toggling --> | <!-- Collect the nav links, forms, and other content for toggling --> | ||
| − | <div | + | <div> |
| − | <ul | + | <ul> |
<!-- Hidden li included to remove active class from about link when scrolled up past about section --> | <!-- Hidden li included to remove active class from about link when scrolled up past about section --> | ||
<li> | <li> | ||
| Line 152: | Line 148: | ||
</nav> | </nav> | ||
</div> | </div> | ||
| − | |||
<!-- jQuery --> | <!-- jQuery --> | ||
Revision as of 10:38, 14 September 2017
<!DOCTYPE HTML>
Incell: a platform for synthetic endosymbiosis
Incell is a new synthetic biology platform with near future applications in research, industry and services. We are rewriting nature’s code for endosymbiosis and transforming an evolutionary phenomenon into a technology compatible with standard biological parts.
Our vision is to produce synthetic host–endosymbiont systems. We set out with a trinity of experiments intrinsic to the synthetic reconstruction of endosymbiosis. First, creating and sustaining dependence between a host and its endosymbionts by fulfilling the amino acid requirement of an auxotrophic host. Next, to build a modular system of cell-penetrating peptides for protein transport of host nuclear encoded proteins into an endosymbiont, recapitulating a crucial feature of the natural process. Finally, regulating the number of endosymbionts within a host using a CRISPR-Cas system for control of replication.
Further ahead we see a safe, customisable, sustainable technology providing biological solutions to present and future challenges in biotechnology, agriculture and medicine.
